Trial Profile
Phase I trial of amuvatinib in patients with glioblastoma.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 12 Feb 2013
Price :
$35
*
At a glance
- Drugs Amuvatinib (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- 26 Sep 2012 Status changed from planning to discontinued prior to trial initiation.
- 13 Aug 2008 New trial record.